COOL - PolarityTE, Inc.

. Currency in USD
-
-
Stock chart is not supported by your current browser
Previous CloseN/A
OpenN/A
BidN/A x N/A
AskN/A x N/A
Day's RangeN/A - N/A
52 Week Rangeundefined - undefined
VolumeN/A
Avg. VolumeN/A
Market CapN/A
Beta (3Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Thomson Reuters StreetEvents2 hours ago

    Edited Transcript of COOL earnings conference call or presentation 14-Jan-19 1:00pm GMT

    Q4 2018 Polarityte Inc Earnings Call

  • Thomson Reuters StreetEvents4 months ago

    Edited Transcript of COOL earnings conference call or presentation 12-Sep-18 12:00pm GMT

    Q3 2018 Polarityte Inc Earnings Call

  • How Financially Strong Is PolarityTE Inc (NASDAQ:COOL)?
    Simply Wall St.4 months ago

    How Financially Strong Is PolarityTE Inc (NASDAQ:COOL)?

    The direct benefit for PolarityTE Inc (NASDAQ:COOL), which sports a zero-debt capital structure, to include debt in its capital structure is the reduced cost of capital. However, the trade-off isRead More...

  • PolarityTE, Inc. Reports Financial Results and Corporate Update for Quarter End July 31, 2018
    PR Newswire4 months ago

    PolarityTE, Inc. Reports Financial Results and Corporate Update for Quarter End July 31, 2018

    SALT LAKE CITY, Sept. 12, 2018 /PRNewswire/ -- PolarityTE, Inc. (COOL), a commercial-stage biotechnology and regenerative biomaterials company focused on transforming the lives of patients by discovering, designing and developing a range of regenerative tissue products for the fields of medicine, biomedical engineering and material sciences, today reported its financial results and corporate update for the quarter ended July 31, 2018. In the nine months ended July 31, 2018, we recognized $432 thousand in total revenue, of which $260 thousand was net sales of SkinTE and $172 thousand was associated with contract research operations in Veterinary Sciences.

  • PolarityTE Awarded Best Presentation at the 2018 American Professional Wound Care Association 17th Annual National Clinical Conference for SkinTE Technology and Clinical Outcomes
    PR Newswire4 months ago

    PolarityTE Awarded Best Presentation at the 2018 American Professional Wound Care Association 17th Annual National Clinical Conference for SkinTE Technology and Clinical Outcomes

    SALT LAKE CITY , Sept. 11, 2018 /PRNewswire/ -- PolarityTE, Inc. (Nasdaq: COOL), a commercial-stage biotechnology and regenerative biomaterials company focused on transforming the lives of patients by ...

  • PolarityTE, Inc. Issues Statement Regarding Mr. John Stetson and his Termination from the Company
    PR Newswire4 months ago

    PolarityTE, Inc. Issues Statement Regarding Mr. John Stetson and his Termination from the Company

    PolarityTE's management team and Board of Directors are committed to upholding the highest standards of integrity. Following the SEC's announcement on September 7, 2018 entitled, "SEC Charges Microcap Fraudsters for Roles in Lucrative Market Manipulation Schemes," the Company immediately terminated Mr. Stetson.

  • Benzinga4 months ago

    Opko Health Under Fire From The SEC; Mark Cuban Confirms He's Short The Stock

    Financier Barry Honig,  Opko Health Inc. (NASDAQ: OPK ) and  Riot Blockchain, Inc. (NASDAQ: RIOT ) CEO John O'Rourke were among those named as defendants in a securities fraud lawsuit filed Friday by the ...

  • PR Newswire4 months ago

    PolarityTE Announces Podium Presentation of SkinTE™ Abstract at the 17th Annual National Clinical Conference of the American Professional Wound Care Association

    SALT LAKE CITY , Sept. 4, 2018 /PRNewswire/ -- PolarityTE, Inc. (Nasdaq: COOL) today announced that it will present an abstract entitled, "Regeneration of Full Thickness Hair-Bearing Skin in Chronic ...

  • PR Newswire5 months ago

    PolarityTE to Report Fiscal Third Quarter Financial Results on September 12, 2018

    SALT LAKE CITY, Aug. 31, 2018 /PRNewswire/ -- PolarityTE, Inc. (COOL), a commercial-stage biotechnology and regenerative biomaterials company focused on transforming the lives of patients by discovering, designing and developing a range of regenerative tissue products for the fields of medicine, biomedical engineering and material sciences, today announced it will report its fiscal third quarter 2018 financial results by press release on September 12, 2018 at approximately 7:30am Eastern Time. In addition, the company will host a live conference call and webcast on Wednesday September 12, 2018 at 8:00am Eastern Time. The conference call can be accessed by calling 1-800-289-0438 (U.S. and Canada) or +44 (0)330 336 9105 (International), with the passcode 7501376. A replay of the earnings call will be available for 12 months, beginning approximately one hour post the conclusion of the earnings call, and can be found by visiting PolarityTE's website at https://ir.polarityte.com/ir-calendar or using the link above.

  • PR Newswire5 months ago

    PolarityTE, Inc. to Participate in Several Upcoming Healthcare Conferences

    SALT LAKE CITY, Aug. 29, 2018 /PRNewswire/ -- PolarityTE, Inc. (COOL), a commercial-stage biotechnology and regenerative biomaterials company focused on transforming the lives of patients by discovering, designing and developing a range of regenerative tissue products for the fields of medicine, biomedical engineering and material sciences, today announced it will attend several upcoming healthcare conferences.  Notably, PolarityTE will participate in the Wells Fargo Securities 2018 Healthcare Conference on Thursday, September 6 and the Morgan Stanley 2018 Global Healthcare Conference on Thursday, September 13. Live audio webcasts will be available on the "News/Events" section of PolarityTE's Investor website at https://ir.polarityte.com/news-events. PolarityTE is a commercial-stage biotechnology and regenerative biomaterials company focused on transforming the lives of patients by discovering, designing and developing a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering and material sciences.

  • ACCESSWIRE5 months ago

    DEADLINE TODAY: The Schall Law Firm Announces it is Investigating Claims Against PolarityTE, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

    LOS ANGELES, CA / ACCESSWIRE / August 27, 2018 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of PolarityTE, Inc. ("PolarityTE" or the "Company") (NASDAQ: COOL) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

  • Business Wire5 months ago

    MONDAY DEADLINE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against PolarityTE, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

    The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against PolarityTE, Inc. (“PolarityTE” or ''the Company'') (NASDAQ: COOL) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's shares between March 31, 2017 and June 22, 2018, inclusive (the ''Class Period''), are encouraged to contact the firm before August 27, 2018. We also encourage you to contact Brian Schall, or Sherin Mahdavian, of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge.

  • ACCESSWIRE5 months ago

    DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against PolarityTE, Inc. (COOL) & Lead Plaintiff Deadline - August 27, 2018

    NEW YORK, NY / ACCESWIRE / August 24, 2018 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against PolarityTE, Inc. ("PolarityTE" or the "Company") (COOL) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired PolarityTE securities between March 31, 2017 and June 22, 2018 (the "Class Period"). This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934. On June 25, 2018, Citron Research released a report calling PolarityTE a "fraud," and accused the Company of failing to disclose that its key technology has been rejected by the United States Patent and Trademark Office, just days before the Company's offering.

  • ACCESSWIRE5 months ago

    SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in PolarityTE, Inc. of Class Action Lawsuit and Upcoming Deadline - COOL

    NEW YORK, NY / ACCESSWIRE / August 22, 2018 / Pomerantz LLP announces that a class action lawsuit has been filed against PolarityTE ("PolarityTE" or the "Company") (COOL) and certain of its officers. The class action, filed in United States District Court, District of Utah, and docketed under 18-cv-00541, is on behalf of a class consisting of all persons other than Defendants who purchased or otherwise acquired PolarityTE securities between March 31, 2017 and June 22, 2018, both dates inclusive (the "Class Period"). Plaintiff seeks to recover compensable damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the "Exchange Act") and Rule 10b-5 promulgated thereunder.

  • ACCESSWIRE5 months ago

    DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against PolarityTE, Inc. (COOL) & Lead Plaintiff Deadline - August 27, 2018

    NEW YORK, NY / ACCESSWIRE / August 21, 2018 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against PolarityTE, Inc. ("PolarityTE" or the "Company") (COOL) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired PolarityTEsecurities between March 31, 2017 and June 22, 2018 (the "Class Period"). This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934. On June 25, 2018, Citron Research released a report calling PolarityTE a "fraud," and accused the Company of failing to disclose that its key technology has been rejected by the United States Patent and Trademark Office, just days before the Company's offering.

  • ACCESSWIRE5 months ago

    PolarityTE, Inc. Reminder: Pawar Reminds of Important August 27, 2018 Lead Plaintiff Deadline in Class Action - COOL

    NEW YORK, NY / ACCESSWIRE / August 20, 2018 / Pawar Law Group reminds shareholders who purchased shares of PolarityTE, Inc. (COOL) between March 31, 2017 and June 22, 2018, both dates inclusive (the "Class Period") of the important August 27, 2018 lead plaintiff deadline in the class action. To join the PolarityTE class action, go to http://pawarlawgroup.com/cases/polarityte-inc/ or call Vik Pawar, Esq. According to the lawsuit, throughout the Class Period defendants made false and/or misleading statements, as well as failed to disclose material adverse facts about PolarityTE's business, operations, and prospects.